We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,430 results
  1. Adeno-associated virus as a delivery vector for gene therapy of human diseases

    Adeno-associated virus (AAV) has emerged as a pivotal delivery tool in clinical gene therapy owing to its minimal pathogenicity and ability to...

    Jiang-Hui Wang, Dominic J. Gessler, ... Guang** Gao in Signal Transduction and Targeted Therapy
    Article Open access 03 April 2024
  2. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1

    Background

    The inducible Kras/p53 lung adenocarcinoma mouse model, which faithfully recapitulates human disease, is routinely initiated by the...

    Haibin Deng, Huixiang Ge, ... Thomas Michael Marti in Cancer Immunology, Immunotherapy
    Article Open access 05 October 2023
  3. Hepatotoxicity in Adeno-Associated Viral Vector Gene Therapy

    Purpose of Review

    Recombinant adeno-associated virus (rAAV) is the commonest viral vector used in gene therapies. With the increase in the number of...

    Barath Jagadisan, Anil Dhawan in Current Hepatology Reports
    Article Open access 20 December 2023
  4. Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss

    Adeno-associated viruses (AAVs) are viral vectors that offer an excellent platform for gene therapy due to their safety profile, persistent gene...

    Fan Wu, Kumar Sambamurti, Suhua Sha in Journal of the Association for Research in Otolaryngology
    Article 24 August 2022
  5. A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient

    Background

    Adeno-associated virus (AAV)-based gene therapy for haemophilia has advanced substantially in the last 13 years; recently, three products...

    Wolfgang Miesbach, Greta Mulders, ... Ingrid Pabinger in Orphanet Journal of Rare Diseases
    Article Open access 13 May 2024
  6. Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology

    There is a compelling need to develop disease-modifying therapies for Alzheimer’s disease (AD), the most common neuro-degenerative disorder. Together...

    Yunseon Yang, Min-Jong Seok, ... Sang-Hun Lee in Molecular Psychiatry
    Article 29 July 2022
  7. Construction of Tissue-engineered Cartilage In Vivo from Microtia Chondrocytes After Transfection with Human VEGF165 Genes Mediated by a Recombinant Adeno-Associated Viral Vector

    Objective

    To evaluate the transfection efficiency of cultured chondrocytes from individuals with microtia (microtia chondrocytes) with the recombinant...

    Zhen Cai, Liyuan Zhang, ... Dongjun Guo in Aesthetic Plastic Surgery
    Article 23 May 2022
  8. Protocol: Adeno-Associated Virus-Mediated Gene Transfer in Ex Vivo Cultured Embryonic Mammary Gland

    Branching morphogenesis of the murine mammary gland starts during late embryogenesis. It is regulated by the signals emanating both from the...

    Qiang Lan, Marja L. Mikkola in Journal of Mammary Gland Biology and Neoplasia
    Article Open access 02 October 2020
  9. A Kaposi’s sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy

    Dilated cardiomyopathy (DCM) is the leading cause of heart transplantation. By microRNA (miRNA) array, a Kaposi’s sarcoma-associated herpes virus...

    Yanru Zhao, Hua** Li, ... Dao Wen Wang in Signal Transduction and Targeted Therapy
    Article Open access 09 June 2023
  10. Host cell factors involved in classical swine fever virus entry

    Classical swine fever virus (CSFV) is an ancient pathogen that continues to pose a threat to animal agriculture worldwide. The virus belongs to the...

    Yaneysis Lamothe-Reyes, Maximiliano Figueroa, Oliberto Sánchez in Veterinary Research
    Article Open access 01 December 2023
  11. Optogenetic activation of the lateral habenulaD1R–ventral tegmental area circuit induces depression-like behavior in mice

    A number of different receptors are distributed in glutamatergic neurons of the lateral habenula (LHb). These glutamatergic neurons are involved in...

    **aowei Chen, **aofeng Liu, ... Hua Zhao in European Archives of Psychiatry and Clinical Neuroscience
    Article 18 January 2024
  12. Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children

    Background

    The COVID-19 pandemic and the consequently adopted worldwide control measures have resulted in global changes in the epidemiology and...

    Ahmed Abushahin, Haneen Toma, ... Ibrahim Janahi in BMC Pediatrics
    Article Open access 02 February 2024
  13. Respiratory illness virus infections with special emphasis on COVID-19

    Viruses that emerge pose challenges for treatment options as their uniqueness would not know completely. Hence, many viruses are causing high...

    Lekha Gandhi, Deepti Maisnam, ... Musturi Venkataramana in European Journal of Medical Research
    Article Open access 08 November 2022
  14. Etranacogene Dezaparvovec: First Approval

    Etranacogene dezaparvovec (etranacogene dezaparvovec-drlb; Hemgenix ® ) is an adeno-associated virus vector-based gene therapy being developed by...

    Young-A Heo in Drugs
    Article 21 February 2023
  15. Gene therapy for liver diseases — progress and challenges

    Gene therapy is poised to revolutionize modern medicine, with seemingly unlimited potential for treating and curing genetic disorders. For otherwise...

    Nerea Zabaleta, Carmen Unzu, ... Gloria Gonzalez-Aseguinolaza in Nature Reviews Gastroenterology & Hepatology
    Article 16 January 2023
  16. Valoctocogene Roxaparvovec: First Approval

    Valoctocogene roxaparvovec (ROCTAVIAN ) is a gene therapy being developed by BioMarin Pharmaceutical Inc. for the treatment of haemophilia A. In...

    Hannah A. Blair in Drugs
    Article 01 September 2022
  17. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies

    Adeno-associated virus (AAV)-derived vectors are currently the most common type of viral vectors used in gene therapy clinical trials. The presence...

    Majid Lotfinia, Meghdad Abdollahpour-Alitappeh, ... Morteza Karimipoor in Clinical and Experimental Medicine
    Article 03 May 2019
Did you find what you were looking for? Share feedback.